MaxCyte Inc. (NASDAQ:MXCT) price on Friday, August 27, rose 12.38% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $15.80.
A look at the stock’s price movement, the close in the last trading session was $14.06, moving within a range at $14.06 and $15.98. The beta value (5-Year monthly) was 1.00. Turning to its 52-week performance, $17.44 and $5.85 were the 52-week high and 52-week low respectively. Overall, MXCT moved 170.09% over the past month.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 6 recommend MXCT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MXCT’s current price about 3.43% and 17.05% off the 20-day and 50-day simple moving averages respectively. The 7-day volatility ratio is 8.05% and 7.39% in the 30-day chart. Further, MaxCyte Inc. (MXCT) has a beta value of 0, and an average true range (ATR) of 1.62. Analysts have given the company’s stock an average 52-week price target of $18.22, forecast between a low of $13.86 and high of $22.00. Looking at the price targets, the low is 12.28% off current price level while to achieve the yearly target high, price needs to move -39.24%. Nonetheless, investors will most likely welcome a -17.09% jump to $18.50 which is the analysts’ median price.
In the market, a comparison of MaxCyte Inc. (MXCT) and its peers suggest the former has performed considerably stronger. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.88% and 0.69% respectively in the last trading.
If we refocus on MaxCyte Inc. (NASDAQ:MXCT), historical trading data shows that trading volumes averaged 584.19K over the past 3 months.
The 16.93% of MaxCyte Inc.’s shares are in the hands of company insiders while institutional holders own 57.34% of the company’s shares. Current price change has pushed the stock 869.33% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MXCT stock continues to rise going into the next quarter.